Workshop on Monoclonal Antibodies in Cancer
October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.
Schedule at a Glance (subject to change)
Friday, October 1, 2010
|
|
6:30 am - 5:00 pm |
Registration Desk Open |
|
7:00 am - 8:00 am |
Breakfast |
|
8:00 am - 8:15 am |
Welcome & Overview
George J. Weiner, MD - University of Iowa |
|
8:15 am - 10:05 am |
Session 1: Tumor-Targeted Antibodies
Chair: Ira Mellman, PhD - Genentech, Inc.
Speakers/Panelists:
"Targeting Activated HER2 in Solid Tumors"
Mark X. Sliwkowski, PhD - Genentech, Inc.
"Combining Tumor Reactive mAbs with Cytokines to Induce ADCC in Patients"
Paul M. Sondel, MD, PhD - University of Wisconsin, Madison
|
10:05 am - 10:30 am
|
Break |
|
10:30 am - 12:00 pm |
Session 2: Immunomodulatory Antibodies
Chair: Glenn Dranoff, MD - Dana-Farber Cancer Institute
Speakers/Panelists:
Lieping Chen, MD, PhD - Johns Hopkins University School of Medicine
"Immunomodulation through the B7-H1/PD-1 axis"
Suzanne L. Topalian, MD - Johns Hopkins University School of Medicine
|
12:00 pm - 1:00 pm
|
Lunch Break |
|
1:00 pm - 2:30 pm |
Session 3: Investigating Antibodies as "Vaccines"
Chair: Ira Mellman, PhD - Genentech, Inc.
Speakers/Panelists:
Raphael Clynes, MD, PhD - Colubmia University
"Antibody-Targeted Vaccines"
Tibor Keler, PhD - Celldex Therapeutics, Inc. |
2:30 pm - 3:00 pm
|
Break |
|
3:00 pm - 5:00 pm |
Session 4: Antibody Engineering
Chair: George J. Weiner, MD - University of Iowa
Speakers/Panelists:
"T Cell Engaging BiTE Antibodies for Cancer Therapy"
Patrick A. Baeuerle, PhD - Micromet, Inc.
"Two-in-One Antibodies"
Germaine Fuh - Genentech, Inc.
"Engineered Anti-cancer Antibodies with Enhanced Effector Functions"
Pablo Umaña, PhD - Roche Glycart AG |
|
|
|
Saturday, October 2 - Monday, October 4
|
iSBTc 25th Annual Meeting
Separate Registration is required. For more information, including the schedule, please click here. |
|
|
|
